Abstract Osteoporosis is a common skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. We previously demonstrated that Col1a1-SOX9 transgenic (TG) mice, in which SOX9 specifically expresses in osteoblasts driven by a 2.3-kb Col1a1 promoter, display osteopenia during the early postnatal stage. In this study, to further analyze the osteopenia phenotype and especially the effect of the osteoblast-specific expression of SOX9 on bone mechanical properties, we performed bone geometry and mechanical property analysis of long bones from Col1a1-SOX9 TG mice and wild-type littermates (WT) at different time points. Interestingly, after body weight adjustment, TG mice had similar whole-bone strength as WT mice but significantly thinner cortical bone, lower elastic modulus, and higher moment of inertia. Thus, osteoblast-specific SOX9 expression results in altered bone structure and material properties. Furthermore, the expression levels of Pcna, Col1a1, osteocalcin, and the Opg/Rankl ratio in TG mice were significantly lower until 4 months of age compared with WT mice, suggesting that TG mice have dysregulated bone homeostasis. Finally, bone marrow stromal cells (MSCs) isolated from TG mice display enhanced adipocyte differentiation and decreased osteoblast differentiation in vitro, suggesting that osteoblast-specific expression of SOX9 can lead to altered mesenchymal stem cell differentiation potentials. In conclusion, our study implies that SOX9 activity has to be tightly regulated in the adult skeleton to ensure optimal bone quality.
role in regulating osteoblast differentiation and function [1, 2] . Runx2 has been shown to regulate all the major genes expressed by osteoblasts in tissue culture [3] . Mouse genetic studies show that homozygous Runx2 null mice have a complete lack of all mineralized skeletal elements due to the absence of osteoblast differentiation [4, 5] . Transgenic Runx2-overexpressing mouse models reveal that Runx2 also regulates postnatal bone formation and bone remodeling [6] [7] [8] . Importantly, mutations in RUNX2 result in cleidocranial dysplasia, a dominantly inherited skeletal dysplasia [9] [10] [11] [12] . Furthermore, increasing evidence suggests that subtle polymorphic variations in RUNX2 could also regulate bone mineral density (BMD) in the general population [13, 14] . Thus, RUNX2 itself has been proposed as one of the candidate genes for osteoporosis [15] .
HMG-domain transcription factor Sox9 is a potent transcriptional activator of chondrocyte-specific genes such as Col2a1, Col11a1, and Aggrecan [16] . Sox9 is essential for successive stages of chondrocyte differentiation and cartilage formation as demonstrated by human and mouse genetic studies [17] [18] [19] . Interestingly, both Sox9 and Runx2 are expressed in osteochondroprogenitor cells, and our previous study demonstrated the dominance of SOX9 function over RUNX2 during skeletogenesis [20] . SOX9 and RUNX2 directly interact with each other via their respective DNA binding domains. SOX9 decreases RUNX2 binding to its target sequences and drastically inhibits RUNX2 transactivation of osteoblast-specific enhancers. Importantly, SOX9 expression diminishes when osteochondroprogenitor cells further differentiate into osteoblasts, and the significance of downregulating SOX9 expression in osteoblasts remains speculative [21] . Interestingly, the TG mice-in which either the full-length or RUNX2-interacting domain of SOX9 specifically expresses in osteoblasts driven by a 2.3-kb Col1a1 promoterdisplay dwarfism and osteopenia at 6 weeks of age, with significantly reduced bone volume and a decreased number of osteoblasts and bone formation rate, defective osteoblast function and mineralization, and downregulation of osteoblast differentiation markers [20] . However, the effect of SOX9 expression in osteoblasts on bone mechanical properties remains unknown.
Bone marrow is constituted of two separate and distinct stem cell populations: hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs, also termed marrow stromal cells) [22, 23] . While MSCs differentiate into osteoblasts, adipocytes, chondrocytes, and myoblasts as determined by different cell type-specific transcription factors [24] [25] [26] [27] [28] , a recent report shows that human perivascular cells give rise to adherent, multilineage progenitor cells that exhibit MSC features [29] . However, the direct effects of osteoblasts on MSC differentiation remain poorly understood. Interestingly, there appears to be antagonism between osteoblastic and adipogenic cell lineage differentiation in MSCs. Indeed, besides being a transcriptional activator essential for osteoblast differentiation and chondrocyte maturation, Runx2 is also a repressor of adipocyte differentiation. Runx2-deficient chondrocytes and osteoblasts can differentiate into adipocytes at increased frequency [30, 31] .
In this study, to further analyze the osteopenia phenotype, especially at the adult stage in Col1a1-SOX9 TG mice, we performed a detailed mechanical property analysis of adult long bone from Col1a1-SOX9 TG mice and wild-type littermates (WT). To explore the underlying molecular mechanisms of SOX9 function in regulating bone mechanical properties, we evaluated the expressions of bone-related markers in TG and WT adult long bones at different time points. Finally, to investigate the potential effect of SOX9-expressing osteoblasts on MSC differentiation, we isolated MSCs and analyzed their differentiation potential in Col1a1-SOX9 TG mice.
Materials and Methods

Animals
Col1a1-SOX9 FL or Col1a1-SOX9 NT TG mice were generated and genotyped as previously reported and maintained on a FVB/N background (Fig. 1a) [20] . All mice were maintained and housed at the Case Western Reserve University animal facility under standard conditions. All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee of Case Western Reserve University. At ages 1, 2, 4, and 6 months, age-and sex-matched TG and WT mice were killed for mechanical tests (see Supplemental Table 1 for the numbers of mice used) and molecular analysis (additional three to six mice per genotype at each time point). Whole skeletons and dissected hind limbs were analyzed by contact radiography taken at the same time for TG and WT mice by a radiographic inspection unit (Faxitron, McMinnville, Oregon).
Bone Mechanical Analysis
Femurs were dissected and cleaned of soft tissue, wrapped in saline-soaked gauze, sealed in airtight containers, and stored at -20°C until mechanical testing. Left femurs were tested by three-point bending; right femurs were used for geometric analysis (as below). Specimens were thawed in saline and placed posterior side down on the bottom pins of a bending fixture (5-mm span between lower pins, 0.75-mm-diameter pins) within a materials testing device (Electroforce 3400; Bose, Eden Prairie, MN). The upper pin was aligned and loading was applied at 0.1 mm/second. The stiffness of the specimen, K, was determined by fitting a linear regression line to the force-displacement curve. Yield strength was evaluated as the point on the forcedisplacement curve where the secant stiffness declined by 10% from the original stiffness [32] . The bending strength was evaluated as the maximum moment applied to the specimen: (ultimate load * span length)/4 (note that maximum moment is directly proportional to ultimate load but accounts for the span length to allow comparisons to other studies).
Right femurs were embedded undecalcified in methyl methyacrylate, and mid-diaphyseal cross sections were cut using a low-speed diamond saw. Cross sections were handpolished, mounted on glass slides, and observed at 409 magnification. Digital images of the cross sections under Fig. 1 Radiographic analysis of skeletons from WT and Col1a1-SOX9 TG mice at different time points. a TG constructs of Col1a1-SOX9 FL and Col1a1-SOX9 NT [20] . b, c Whole-body X-ray of Col1a1-SOX9 FL and Col1a1-SOX9 NT TG mice and their WT littermates at 2 months of age. d X-ray photography of dissected femurs in 1-, 2-, 4-, and 6-month-olds. All images were taken under identical conditions for TG and WT mice. e, f Comparison of body weight and femur length by age. g Comparison of femur length via body weight adjustment. The linear correlations of femur length with body weight were not significantly different between WT and TG mice (P = 0.854). Data are mean ± SD from three to six mice per age and group. *P \ 0.05, **P \ 0.01 UV illumination were collected to visualize the entire bone cross section (4.6 lm/pixel). The periosteal and endosteal diameters in the anterior-posterior (minor) axis and medial-lateral (major) axis were determined by manual measurement from the image using ImageJ (http://rsbweb. nih.gov/ij/). Average thickness of the cross section was calculated directly using a thresholded image and a distance transform method. The second moment of inertia, I, was determined from the thresholded image using custom Matlab software (Mathworks, Natick, MA). The elastic modulus, E, of the bone tissue was estimated using the following equation from beam theory:
where L is the span length (5 mm) and K is the stiffness obtained from the force-displacement curve.
RNA Isolation and Real-Time Reverse-Transcription Polymerase Chain Reaction Analysis
Using TRIzol reagent and Purelink Micro-To-Midi RNA Kit (both from Invitrogen, Carlsbad, CA), total RNA was extracted from fresh femur samples at different time points (n = 3-6/group at each time point). The epiphyses at both ends were cut off and the bone marrow was flushed out with PBS as described [33] . cDNA was prepared from 1 lg total RNA with the iScript cDNA Synthesis Kit (Bio-Rad, Richmond, CA). The Power SYBR Green PCR Master Mix and the 7500 Real Time PCR system (both from Applied Biosystems, Foster City, CA) were used for real-time reverse-transcription polymerase chain reaction (RT-PCR) with gene-specific primers, listed in Table 1 . The Gapdh gene was used as an internal control of the quantity and quality of the cDNAs. Relative gene-expression levels were quantified in triplicate and calculated by the 2 -DDCT method for fold induction as described previously [34] . For MSC isolation, mice were killed at 2 months of age. Bone marrow was immediately flushed out with cold PBS from the femurs and tibias, followed by centrifugation at 4009g for 10 min and cell counting. MSCs were then resuspended to a final concentration of 5 9 10 6 cells/mL in DMEM (HyClone, Logan, UT) with 10% FBS (Invitrogen) as described [35, 36] . MSCs were cultured in a humidified 5% CO 2 incubator at 37°C for 72 h before nonadherent cells were removed by changing the medium. MSCs were then cultured in 6-cm dishes at 1 9 10 7 cells/dish for 10 days. After washing with PBS twice, dishes were stained with toluidine blue for fibroblast colony-forming units (CFU-F).
At 50-70% confluence, MSCs were further passaged two or three times before differentiation induction as described [35, 36] . For adipocyte differentiation, after cells reached confluence, adipogenesis was stimulated by three induction/ maintenance cycles. Each cycle consisted of 3-day culturing of MSCs with adipogenesis induction DMEM, which contains 10% FBS, 10 lg/mL ITS (Insulin-TransferrinSodium Selenite Supplement; Roche, Mannheim, Germany), 0.2 mM indomethacin, and 1 lM dexamethasone. Cells were then cultured for 3-4 days in adipogenesis maintenance DMEM, which contains 10% FBS and 1 lM dexamethasone. Cells were then fixed, washed with PBS, and stained with 0.5% oil red O (Sigma, St. Louis, MO) in GTGGTTCACACCCATCACAA isopropyl alcohol for 1 h, followed by PBS washing. Osteogenesis differentiation was induced by culturing MSCs for up to 4 weeks in DMEM containing 10% FBS, 50 mg/mL ascorbic acid, 10 mM b-glycerophosphate, and 10 -8 M dexamethasone. To observe calcium deposition, cells were washed once with PBS and stained with alizarin red S solution for 5 min at room temperature.
Histology and Green Fluorescent Protein Analysis
For histological analysis, tibias were collected from 8-weekold Col1a1-SOX9 TG mice and WT littermates, decalcified, and then embedded in paraffin, followed by hematoxylin and eosin staining. For green fluorescent protein (GFP) TG MSC analysis, MSCs were collected as described above from 8-week-old osteoblast-specific 2.3 Col1a1-GFP TG mice (a kind gift from Dr. David Rowe, Department of Reconstructive Sciences, School of Dental Medicine, University of Connecticut Health Center, Farmington, Connecticut) [37] , CAG-EGFP TG mice that ubiquitously express GFP (Jackson Laboratory, Bar Harbor, ME; #006053), and WT littermates. After 12-day culture, MSCs were subjected to fluorescence microscopic analysis as described [37] .
Statistical Analysis
Results were given as mean ± standard deviations (SD). Statistical analysis was performed by Student's t-test to compare the differences in gene expression between agematched Col1a1-SOX9 TG mice and WT littermates (n = 3-6). The linear correlations between geometry, mechanical property data, and body weight were calculated by Microsoft (Redmond, WA) Excel. To compare the difference in linear correlation, statistical analysis was performed by ANCOVA test with XLSTAT 2009 (http:// xlstat-2009.fyxm.net/) to detect differences in stiffness and strength after accounting for body weight. The ANCOVA was implemented using a generalized least squares model with body weight as a covariate [38] . P \ 0.05 was considered statistically significant.
Results
Radiographic Analysis of Col1a1-SOX9 TG Skeletons
Whole-body X-ray analysis confirmed the dwarfism phenotype in 2-month-old Col1a1-SOX9 full length (SOX9 FL) (Fig. 1b) and Col1a1-SOX9 N-terminal (SOX9 NT) (Fig. 1c ) TG mice [20] . X-ray photography of dissected femurs showed that both length and bone mineralization were reduced in Col1a1-SOX9 FL TG mice at 1 month and 2 months (Fig. 1d) . Col1a1-SOX9 FL TG mice had more translucent and wider femurs until 6 months of age, suggesting compromised bone mineralization and altered bone geometry (Fig. 1d) . Body weight was also significantly lower (Fig. 1e) , and the femur length was significantly shorter until age 4 months in Col1a1-SOX9 FL TG mice compared with WT littermates (Fig. 1f) . The differences in femur length between TG and WT mice appeared to be much reduced at later time points. Indeed, at age 6 months, TG mice had femur lengths similar to those of WT mice (Fig. 1f ). There were similar linear correlations between femur length and body weight in WT and TG mice (WT vs. TG, P = 0.854) (Fig. 1g) . Thus, for the same body weight, there was no significant difference in femur length between WT and TG mice.
Bone Geometry At 1 month of age, Col1a1-SOX9 FL TG mice exhibited severely decreased cortical bone thickness compared with WT littermates (Fig. 2a) . Although cortical bone thickness increased in TG mice 2-4 months old, it was still lower than that of WT (Fig. 2a) . Additionally, both the femoral periosteal diameter and the endosteal diameter of TG mice were wider than those of WT littermates at all time points (Fig. 2b,  d ). The average cortical bone thickness of TG mice was also significantly lower than that of WT littermates until 4 months of age (Fig. 2f) . Importantly, after body weight adjustment, the differences in periosteal diameter, endosteal diameter, and average cortical bone thickness were even more dramatic. There were significant differences in the linear correlations between WT and TG mice (P \ 0.01) (Fig. 2c, e, g ). Thus, for the same body weight, TG mice had wider and thinner cortical bone than WT mice.
Biomechanical Analysis
To evaluate the effect of the osteoblast-specific expression of SOX9 on bone mechanical strength, we performed a standard three-point bending assay. Stiffness, yield moment, and maximum moment were all significantly decreased in SOX9 FL TG mice compared with WT littermates at all time points we tested (Fig. 3a-c) . However, with body weight adjustment, there was no significant difference in maximum moment between WT and TG mice (Fig. 3d) . Thus, for the same body weight, TG and WT mice had similar whole-bone strength.
In both TG and WT mice, there was a linear correlation between elastic modulus and body weight (Fig. 3f) . However, elastic modulus was significantly lower in TG than in WT mice at all time points we tested (Fig. 3e) . Importantly, for the same body weight, TG mice appear to have more compliant bone tissue material with significantly lower elastic modulus than WT mice (P \ 0.01) (Fig. 3f) .
Interestingly, TG mice had a moment of inertia similar to that of WT littermates at the same age (Fig. 3g) . There was also a linear correlation between moment of inertia and body weight in both TG and WT mice (Fig. 3h) . In contrast with the elastic modulus, the slope of the moment of inertia was significantly higher for TG than for WT mice after body weight adjustment (P \ 0.01). Thus, femurs showed wider bone in TG than WT mice at the same body weight, consistent with the geometric data, which showed that TG mice have wider and thinner cortical bone (Fig. 2c, e, g ). Together, our data show that despite their more compliant bone tissue, at the same body weight, Col1a1-SOX9 FL TG mice appear to achieve whole-bone biomechanical performance similar to that of WT by compensating with altered bone geometry, namely, an increased second moment of inertia through wider and thinner cortices.
We have previously shown that-similar to Col1a1-SOX9 FL, which contains a full-length SOX9 constructanother TG mouse line, Col1a1-SOX9 NT, which harbors only the N-terminal RUNX2-interacting domain of SOX9, also exhibits osteopenia with defective osteoblast function (Fig. 1c) [20] . To confirm our findings in Col1a1-SOX9 FL TG mice and to investigate whether the bone biomechanical changes in mutant mice depend on the RUNX2-interacting domain of SOX9, we performed the same mechanical test in the Col1a1-SOX9 NT TG mouse line (Fig. 4a) . The bone parameter data in Col1a1-SOX9 NT and WT littermates at 2 months of age-including body Fig. 2 Geometric analysis of cortical bone. a Representative middiaphyseal femur cross section shows significant reduction in cortical bone thickness in Col1a1-SOX9 FL TG mice. b, d, f Comparison of periosteal diameter, endosteal diameter, and cortical bone thickness in 1-, 2-, 4-, and 6-month-olds. c, e, g Comparison of the linear correlations of periosteal diameter, endosteal diameter, and cortical bone thickness between WT and TG mice after body weight adjustment. For the same body weight, TG mice have wider periosteal diameter, wider endosteal diameter, and thinner cortical bone than WT mice. Data are mean ± SD from three to six mice per age and group. *P \ 0.05, **P \ 0.01 weight, femur length, stiffness, yield moment, maximum moment, moment of inertia, and elastic modulus-were consistent with those in the Col1a1-SOX9 FL line (Fig. 4b-h ). Hence, Col1a1-SOX9 NT TG mice had a similar biomechanical performance as Col1a1-SOX9 FL TG mice. This suggests that the SOX9 effect on bone material and geometry is likely due to its RUNX2-interacting N terminus, which harbors the HMG DNA-binding domain of SOX9.
Dysregulated Osteoblast-Specific Gene Expression in Col1a1-SOX9 FL TG Mice
To uncover the underlying molecular mechanisms for the altered bone mechanical properties in Col1a1-SOX9 FL TG mice, we extracted RNAs from femurs and performed quantitative real-time RT-PCR analysis for osteoblast proliferation and function. We first confirmed the transgene expression in Col1a1-SOX9 FL TG mice at all time points (data not shown). To evaluate osteoblast proliferation status, we quantified the expression level of Pcna (proliferating cell nuclear antigen), a proliferation marker. Compared with WT femurs, Pcna expression in TG femurs was significantly lower until 4 months of age but significantly higher at 6 months of age (Table 2 ). This suggests that osteoblasts in TG mice might be deficient in proliferation at an early stage but compensate by overproliferating at a later stage. Type I collagen is the most abundant extracellular protein in bone, essential for maintaining skeletal strength. In TG mice, Col1a1 expression was weight and maximum moment, body weight and elastic modulus, and body weight and moment of inertia in WT and TG mice. Data are mean ± SD from three to six mice per age and group. *P \ 0.05, **P \ 0.01 significantly lower at 1, 2, and 4 months of age but significantly higher at 6 months of age than in WT mice ( Table 2) . Osteocalcin is a noncollagenous protein, secreted specifically by osteoblasts, critical for bone mineralization and calcium ion homeostasis. Interestingly, the expression dynamics of osteocalcin were similar to those of Col1a1 in TG mice. Osteocalcin expression level was significantly lower at 1 and 2 months of age, increasing to similar levels at age 4 months and becoming significantly higher at age 6 months in TG than in WT mice (Table 2) . Thus, the expression profiles of Pcna, Col1a1, and osteocalcin suggest that Col1a1-SOX9 FL TG mice might have delayed proliferation and deregulated bone mineralization.
Osteoblasts and osteoclasts are intimately coupled during bone formation and bone remodeling. To assess the effect of osteoblast-specific SOX9 expression on adult bone remodeling, we quantified the bone metabolism markers Opg and Rankl by real-time RT-PCR. Opg is a major negative regulator of bone resorption as an osteoclastogenesis inhibitory factor, while Rankl is a key stimulator of bone resorption. The Opg/Rankl ratio is commonly used as a prognostic indicator of bone remodeling [39] . The Opg/Rankl ratio was significantly lower at age 1 month in TG than in WT mice. But afterward, the Opg/Rankl ratio kept on increasing in TG mice and reached a level similar to that of WT littermates at 2 and 4 months of age. Eventually, the Opg/Rankl ratio was significantly higher at 6 months of age in TG compared with WT mice. The Opg/Rankl ratio changes hint at the dysregulated bone homeostasis in Col1a1-SOX9 FL TG mice. Thus, TG mice might have delayed bone formation and active bone resorption at an early postnatal stage but switch to increased bone formation and decreased bone resorption at later stages. These osteoblast-related geneexpression profiles correlate well with the bone mechanical and geometric data, such as the lower elastic modulus and higher moment of inertia in Col1a1-SOX9 FL TG mice compared with WT mice.
Altered MSC Differentiation in Col1a1-SOX9 FL TG Mice
In bone marrow, osteoblasts might play important roles in regulating MSC maintenance and differentiation, probably To analyze the MSC function in Col1a1-SOX9 FL TG mice, we first performed an in vitro colony formation assay of MSCs derived from Col1a1-SOX9 FL TG mice and WT littermate controls. There was no significant difference in the total colony numbers (CFU-F) (Fig. 5a) , suggesting no significant change in MSC numbers in the bone marrow of TG mice.
To investigate the effect of osteoblast-specific SOX9 expression on MSC differentiation capability, we performed in vitro adipogenesis and osteogenesis induction assays. Interestingly, for both WT and TG mice, MSCs from males exhibited higher osteogenic activity than those of females by alizarin red staining (Fig. 5b ). This suggests a gender difference in murine MSC differentiation potential, which correlates with a previous report showing that mouse skeletal muscle-derived stem cells from males exhibited higher osteogenic activity than those derived from females [40] . Compared with WT, for both male and female, Col1a1-SOX9 FL MSCs appeared to exhibit modestly decreased osteogenic differentiation (Fig. 5b) . However, MSCs from Col1a1-SOX9 FL mice displayed drastically enhanced adipocyte differentiation as assayed by oil red O staining (Fig. 5c ). In addition, histological analysis revealed significantly increased numbers of adipocytes in the bone marrow of Col1a1-SOX9 TG compared with WT mice (Fig. 5d, e) . Thus, ectopic expression of SOX9 in osteoblasts seems to tip the MSC differentiation potential toward adipogenesis. Importantly, 2.3 Col1a1 is a well-characterized promoter that targets only well-differentiated osteoblasts, not MSCs [37, 41] . Consistent with a previous report that the 2.3 Col1a1-GFP transgene was inactive in human MSCs [42] , our 2.3 Col1a1-GFP TG MSC culture experiment indicated that 2.3 Col1a1-targeted osteoblastic-lineage cells were not a major direct contributor to the MSC population in cell culture (Fig. 6a) , suggesting that the changes in ex vivo differentiation potential in MSCs derived from Col1a1-SOX9 TG mice are unlikely to be due to direct expression of the SOX9 transgene itself in MSCs.
Discussion
Bone is a living tissue capable of self-repair, with complex mechanical properties. Bone strength is determined by structural and material properties. Structural properties include features such as bone size, bone geometry, and bone microstructure. Material properties include features such as BMD, chemical composition, and the size of hydroxyapatite crystals [43] . Our previous studies revealed that osteoblasts from Col1a1-SOX9 FL TG mice were less active than those from WT mice. Bone histomorphometric analysis showed that osteoblast numbers and bone formation rates were significantly reduced in TG mice [20] . In the current study, we investigated the mechanical properties of long bone in Col1a1-SOX9 FL TG mice. Interestingly, Col1a1-SOX9 FL TG mice exhibit a lower elastic modulus and higher moment of inertia than WT mice after body weight adjustment. This indicates that, for the same body weight, TG mice have wider bone diameters than WT mice, to compensate for the decreased elastic modulus. The average cortical bone thickness of SOX9 FL TG mice is also significantly lower than that of WT mice until 4 months of age, even after body weight adjustment (Fig. 2f, g ). Thus, these results collectively demonstrate the altered bone structure and bone material in TG mice (Fig. 6b) .
In previous work, we uncovered the downregulation of the osteoblast markers Col1a1 and osteocalcin in Col1a1-SOX9 TG mice at both the newborn and 6-week-old time points [20] . In our present work, we further evaluated the expression of various bone-related markers in Col1a1-SOX9 FL TG mice to explore the underlying molecular mechanisms of SOX9 in regulating bone mechanical properties. Compared with WT, expression of the proliferation marker Pcna in TG mice is significantly lower until age 4 months but increases to a significantly higher level at For each gene at each time point, expression levels in WT values were arbitrarily designated as 1. Gene-expression levels in Col1a1-SOX9 FL TG mice were compared with WT samples to calculate the relative fold changes in TG. Data are mean ± SD from three to six individual mice per genotype and expressed as the fold changes in TG relative to WT mice age 6 months, indicating delayed bone growth in TG mice. Col1a1, osteocalcin, and the Opg/Rankl ratio all display dynamic expression profiles similar to those of Pcna, suggesting delayed bone mineralization and deregulated bone remodeling. These molecular changes are consistent with the inhibitory effect of Sox9 on Runx2 in adult TG mice [20] . Genetic factors play an important role in the pathogenesis of osteoporosis [15] . Among them, Runx2 is a master transcription factor essential for osteoblast differentiation and bone remodeling. The Runx2 gene produces two major transcripts driven by alternative promoters, designated P1 and P2. Interestingly, Runx2-II-deficient mice, which have a P1 promoter and exon 1 deleted, exhibited a low-turnover osteopenia phenotype similar to Col1a1-SOX9 FL TG mice [44, 45] . Runx2-II-deficient mice displayed significantly reduced trabecular bone volume, decreased cortical thickness, and decreased BMD. They also exhibited downregulated osteoblastic and osteoclastic marker expression, decreased bone formation, significant reductions in bone mechanical properties, and impaired MSC differentiation in vitro. Our current study demonstrates that Col1a1-SOX9 FL TG mice also exhibit a significant reduction in cortical bone thickness, stiffness, yield moment, and maximum moment, as well as altered MSC differentiation (Fig. 6b) . Our previous study demonstrated that SOX9 decreases RUNX2 binding to its target sequences and drastically inhibits RUNX2 transactivation of osteoblast-specific enhancers, indicating the dominance of SOX9 function over RUNX2 during skeletogenesis [20] . Another recent study further demonstrated that Sox9 also directly induced Runx2 protein degradation [46] . Interestingly, the phenotypes in Col1a1-SOX9 mice were also very similar to those observed in Col1a1-Sox8 mice, in which the expression of a highly related HMG transcription factor Sox8 was driven by the same Col1a1 promoter element [47] . Cola1-Sox8 mice displayed impaired bone formation characterized by low bone mass, defective osteoblast function, and increased spontaneous fracture occurrence. Furthermore, Col1a1-Sox8 also had decreased expression of Runx2 downstream targets such as Col1a1 and osteocalcin in osteoblasts [47] . Collectively, these three different mouse models show that compromised Runx2 activity leads to osteopenia with altered bone mechanical properties and likely leads to altered MSC differentiation potential. Thus, tight regulation of Runx2 function is critical not only for early embryogenesis but also essential for proper adult bone remodeling.
The osteoblast is part of the well-established HSC niche due to its function in maintaining a quiescent HSC microenvironment in bone marrow. However, the effect of osteoblasts on MSCs residing in bone marrow remains poorly understood. Recently, a new factor was reported as regulating stem cell fate: the elasticity of the matrix microenvironment as a rigid matrix stimulates osteogenic differentiation with elevated osteocalcin expression [48] . Another report indicates that MSCs respond to ECM rigidity in bone through an integrin-ROCK-FAK-ERK1/2 axis during osteogenic differentiation [49] . However, the mechanism of osteoblast impact on MSC differentiation is still largely unclear. In our current study, although an in vitro CFU-F assay showed no significant difference in MSC numbers, MSCs from Col1a1-SOX9 FL TG mice exhibited modestly decreased osteogenic potential compared with WT mice. The decreased osteogenesis potential correlated with the decreased elastic modulus in TG mice. Col1a1-SOX9 FL MSCs also displayed enhanced adipocyte differentiation in vitro. There were also more adipocytes in the bone marrow of TG mice compared with WT mice. Our results correlate with previous reports that MSCs derived from osteoporotic patients exhibited important functional differences compared to MSCs obtained from control donors: decreased osteoblast differentiation, less type I collagen synthesis, and increased adipocyte differentiation [50, 51] . The underlying molecular mechanism for the changes in MSC differentiation in Col1a1-SOX9 TG mice is still unclear and is likely to be complex. It may reflect the above-mentioned effect of the elasticity of the matrix microenvironment on MSCs, the direct interaction between osteoblasts and MSCs, or the effect of some osteoblastsecreted paracrine factor(s) on MSCs. These possibilities do not necessarily exclude each other.
Although cell lineage analysis revealed that Sox9-expressing progenitor cells contribute not only to chondrocytes but also to osteoblasts during embryogenesis, Sox9 expression is extinguished during osteoblast differentiation [21] . However, the importance of downregulating Sox9 expression in osteoblasts is still poorly understood. Interestingly, Sox9 was identified to be associated with Col1a1 promoter in a recent chromatin immunoprecipitation (ChIP)-on-chip study, raising the intriguing possibility that Sox9 can directly inhibit Col1a1 expression in vivo [52] . Additionally, the loss of Sox9 in differentiated chondrocytes resulted in ectopic Col1a1 and Runx2 expression [53] . Thus, Sox9 is likely to repress Col1a1 and Runx2 in differentiated chondrocytes at the transcriptional level. Our current study reveals the adverse effect of misexpressing Sox9 in osteoblasts during mouse postnatal skeletal development and underscores the importance of inhibiting Sox9 activity in osteoblastic cell linage. Thus, it is important to identify the negative regulators of Sox9 in osteochondroprogenitor cells and osteoblasts. In summary, our study shows that tight regulation of SOX9 activity may be critical for maintaining the material and structural integrity of adult bone. A better understanding of SOX9 function in the adult skeleton might lead to improved diagnosis of and therapeutic options for osteoporosis. Furthermore, SOX9 misexpression has been associated with various pathological conditions including fibrosis and cancers [54] . Thus, our study may also shed new light on the mechanism of SOX9-associated disease.
